These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1897193)

  • 21. Mildronate decreases carnitine availability and up-regulates glucose uptake and related gene expression in the mouse heart.
    Liepinsh E; Vilskersts R; Skapare E; Svalbe B; Kuka J; Cirule H; Pugovics O; Kalvinsh I; Dambrova M
    Life Sci; 2008 Oct; 83(17-18):613-9. PubMed ID: 18801379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of some factors controlling fatty acid oxidation in liver mitochondria of obese Zucker rats.
    Clouet P; Henninger C; Bézard J
    Biochem J; 1986 Oct; 239(1):103-8. PubMed ID: 3800970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty acid oxidation and related gene expression in heart depleted of carnitine by mildronate treatment in the rat.
    Degrace P; Demizieux L; Gresti J; Tsoko M; André A; Demaison L; Clouet P
    Mol Cell Biochem; 2004 Mar; 258(1-2):171-82. PubMed ID: 15030182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of bovine hepatic fatty acid oxidation.
    Jesse BW; Emery RS; Thomas JW
    J Dairy Sci; 1986 Sep; 69(9):2290-7. PubMed ID: 3782585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of mitochondrial fatty acid oxidation in pentenoic acid-induced fatty liver. A possible model for Reye's syndrome.
    Thayer WS
    Biochem Pharmacol; 1984 Apr; 33(8):1187-94. PubMed ID: 6712730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats.
    Liepinsh E; Vilskersts R; Zvejniece L; Svalbe B; Skapare E; Kuka J; Cirule H; Grinberga S; Kalvinsh I; Dambrova M
    Br J Pharmacol; 2009 Aug; 157(8):1549-56. PubMed ID: 19594753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondria as the target for mildronate's protective effects in azidothymidine (AZT)-induced toxicity of isolated rat liver mitochondria.
    Pupure J; Fernandes MA; Santos MS; Moreno AJ; Kalvinsh I; Klusa V; Oliveira CR
    Cell Biochem Funct; 2008; 26(5):620-31. PubMed ID: 18508390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of l-carnitine and mildronate on the mitochondrial metabolism of heart and bacterial composition of the gut microbiome in ageing mice.
    Volodina DE; Gureev AP; Shaforostova EA; Gryaznova MV; Ignatyeva DA; Popov VN
    Life Sci; 2022 Mar; 293():120333. PubMed ID: 35051422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of DL-carnitine and gamma-butyrobetaine hydroxylase inhibitor 3-(2,2,2-trimethylhydrazinium) propionate on isoproterenol-induced changes in the metabolism of the rat myocardium].
    Simkhovich BZ; Meĭrena DV; Shutenko ZhV; Khagi KhB; Briede IaL
    Vopr Med Khim; 1988; 34(5):30-4. PubMed ID: 3218133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of mildronate on disorders of the cardiac contractile function in rats caused by an excess of free fatty acids and ischemia].
    Simkhovich BZ; Briede IaL; Ozola RA; Meĭrena DV; Kalvin'sh IIa; Lukevits EIa
    Farmakol Toksikol; 1990; 53(5):27-9. PubMed ID: 2253743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of long-term mildronate treatment on cardiac and liver functions in rats.
    Liepinsh E; Kuka J; Svalbe B; Vilskersts R; Skapare E; Cirule H; Pugovics O; Kalvinsh I; Dambrova M
    Basic Clin Pharmacol Toxicol; 2009 Dec; 105(6):387-94. PubMed ID: 19663820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated peroxisomal fatty acid metabolism improves cardiac recovery in ischemia-reperfusion.
    Liepinsh E; Skapare E; Kuka J; Makrecka M; Cirule H; Vavers E; Sevostjanovs E; Grinberga S; Pugovics O; Dambrova M
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Jun; 386(6):541-50. PubMed ID: 23525500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of metabolites of the propionate pathway on the oxidative activity of liver mitochondria].
    Fedotcheva NI; Gessler NN; Bykhovskiĭ VIa; Kondrashova MN
    Biokhimiia; 1991 Mar; 56(3):426-33. PubMed ID: 1883904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of inhibiting carnitine biosynthesis on male rat sexual performance.
    Dambrova M; Cirule H; Svalbe B; Zvejniece L; Pugovichs O; Zorenko T; Kalvinsh I; Liepinsh E; Belozertseva I
    Physiol Behav; 2008 Oct; 95(3):341-7. PubMed ID: 18640137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of palmitoyl-L-carnitine oxidation in rat liver mitochondria by pent-4-enoyl-L-carnitine.
    Holland PC; Sherratt HS
    Biochem J; 1969 Oct; 114(4):67P. PubMed ID: 5343765
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of fenofibrate treatment on fatty acid oxidation in liver mitochondria of obese Zucker rats.
    Henninger C; Clouet P; Cao Danh H; Pascal M; Bezard J
    Biochem Pharmacol; 1987 Oct; 36(19):3231-6. PubMed ID: 3663237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of the carnitine biosynthesis inhibitor mildronate on the lipid metabolic indices of rats].
    Shutenko ZhV; Priedena IA; Mezhapuke RIa; Simkhovich BZ; Kalvin'sh IIa; Lukevits EIa
    Farmakol Toksikol; 1991; 54(2):55-6. PubMed ID: 1884799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-(2,2,2-Trimethylhydrazinium)propionate (THP)--a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties.
    Simkhovich BZ; Shutenko ZV; Meirena DV; Khagi KB; Mezapuķe RJ; Molodchina TN; Kalviņs IJ; Lukevics E
    Biochem Pharmacol; 1988 Jan; 37(2):195-202. PubMed ID: 3342076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of carnitine acetyltransferase by mildronate, a regulator of energy metabolism.
    Jaudzems K; Kuka J; Gutsaits A; Zinovjevs K; Kalvinsh I; Liepinsh E; Liepinsh E; Dambrova M
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1269-75. PubMed ID: 19912061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypolipidaemic effects of fenofibrate are not altered by mildronate-mediated normalization of carnitine concentration in rat liver.
    Tsoko M; Beauseigneur F; Gresti J; Demarquoy J; Clouet P
    Biochimie; 1998 Nov; 80(11):943-8. PubMed ID: 9893954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.